dexrazoxane has been researched along with Necrosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bize, P; Denys, A; Deplanque, G; Duran, R; Orcurto, A; Shabafrouz, K; Stalder, G | 1 |
Bongoni, AK; Christen, S; Kamat, P; Khattab, AA; Meier, B; Rieben, R; Vandenberghe, S | 1 |
2 other study(ies) available for dexrazoxane and Necrosis
Article | Year |
---|---|
Dexrazoxane prevents skin necrosis in non-target embolization of falciform artery during transcatheter arterial chemoembolization (TACE).
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Dermatologic Agents; Dexrazoxane; Drug Eruptions; Embolization, Therapeutic; Hepatic Artery; Humans; Liver Neoplasms; Male; Necrosis; Skin | 2018 |
Dexrazoxane Shows No Protective Effect in the Acute Phase of Reperfusion during Myocardial Infarction in Pigs.
Topics: Acute Disease; Administration, Intravenous; Animals; Chemokine CCL2; Complement C3c; Complement Membrane Attack Complex; Dexrazoxane; Disease Models, Animal; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Necrosis; Platelet Endothelial Cell Adhesion Molecule-1; Reactive Oxygen Species; Risk Factors; Swine; Troponin I; Ventricular Function, Left | 2016 |